^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CBL0137

    i
    Associations
    News
    Trials
    Company:
    Children's Oncology Group, Incuron, Statera BioPharma
    Drug class:
    NF-κB inhibitor, p53 stimulant, SSRP1 inhibitor
    Related drugs:
    Associations
    News
    Trials